Viewing Study NCT02017457


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-01-04 @ 9:01 AM
Study NCT ID: NCT02017457
Status: COMPLETED
Last Update Posted: 2019-12-10
First Post: 2013-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
Sponsor: Carlos Graux, MD, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module